Table 1 Patient characteristics in the entire collective and by AKI.
Characteristic | All patients | Acute kidney injury (AKI) | P-valuea | |
|---|---|---|---|---|
No | Yes | |||
(N = 33) | (N = 16) | (N = 17) | ||
Demographics | ||||
Age, years | 63.0 ± 16.2 | 65.4 ± 15.1 | 60.8 ± 17.3 | 0.4724 |
Sex (male) | 16 (48.48%) | 10 (62.50%) | 6 (35.29%) | 0.1392 |
BMI, kg/m2 | 25.4 ± 5.0 | 25.9 ± 5.4 | 24.9 ± 4.8 | 0.6156 |
Current smokers | 12 (36.36%) | 6 (37.50%) | 6 (35.29%) | 0.7638 |
Comorbidities | ||||
Chronic kidney disease | 5 (15.15%) | 3 (18.75%) | 2 (11.76%) | 0.8403 |
Coronary heart disease | 14 (42.42%) | 9 (56.25%) | 5 (29.41%) | 0.1471 |
Diabetes mellitus | 6 (18.18%) | 2 (12.50%) | 4 (23.53%) | 0.4807 |
Hypertension | 23 (69.7%) | 14 (87.50%) | 9 (52.94%) | 0.0575 |
COPD | 13 (39.39%) | 8 (50%) | 5 (29.41%) | 0.2593 |
Connective tissue disease (Marfan syndrome) | 5 (15.15%) | 1 (6.25%) | 4 (23.53%) | 0.2609 |
pAVK | 4 (12.12%) | 2 (12.50%) | 2 (11.76%) | 0.9503 |
Maximum aortic diameter, cm | 6.6 ± 1.3 | 6.5 ± 1.4 | 6.7 ± 1.1 | 0.6691 |
Marker at baseline | ||||
Hemoglobin, g/dL | 12.9 ± 1.9 | 12.9 ± 2.3 | 12.8 ± 1.5 | 0.9156 |
Serum creatinine, mg/dL | 1.1 ± 0.4 | 1.2 ± 0.4 | 1.0 ± 0.3 | 0.2413 |
Type of TAAA | ||||
TAAA 1 | 5 (15.15%) | 3 (18.75%) | 2 (11.76%) | 0.3272 |
TAAA 2 | 7 (21.21%) | 2 (12.50%) | 4 (29.41%) | |
TAAA 3 | 7 (21.21%) | 1 (6.25%) | 6 (35.29%) | |
TAAA 4 | 10 (30.3%) | 7 (43.75%) | 3 (17.65%) | |
TAAA 5 | 4 (12.12%) | 3 (18.75%) | 1 (5.88%) | |
